Stay updated on Tepotinib & Gefitinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tepotinib & Gefitinib in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.0 to v3.6.3, signaling a newer site build; no visible content changes to the study details are expected.
    Difference
    0.0%
    Check dated 2026-06-30T01:11:04.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now includes a recruitment status update 'No longer looking for participants' and adds new help/navigation links (How to Read a Study Record, Common Questions, How to Join a Study). A Revision: v3.6.0 notice was added, and the Intervention/Treatment heading formatting was adjusted while the older Revision: v3.5.5 note was removed.
    Difference
    0.3%
    Check dated 2026-06-15T18:47:21.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page displays a new revision label, updating from v3.5.4 to v3.5.5 to reflect a minor update to the study record.
    Difference
    0.0%
    Check dated 2026-06-08T15:30:41.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.4, replacing the previous v3.5.3, indicating an updated set of study documents on the page. This reflects a documentation revision rather than a change to the study data or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-05-18T03:48:46.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Taoyuan, Taiwan has been added as a site and Taoyuan District, Taiwan has been removed from the study locations. This updates the geographic footprint of the trial sites for INSIGHT.
    Difference
    0.0%
    Check dated 2026-05-03T15:50:51.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page’s footer “Revision” has been updated from v3.5.2 to v3.5.3, indicating a platform/version change rather than a change to the trial’s published information.
    Difference
    0.0%
    Check dated 2026-04-26T15:36:33.000Z thumbnail image

Stay in the know with updates to Tepotinib & Gefitinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.